Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
360.00    4.00 (1.12%)
Bid:
355.00
Ask:
362.00
Spread: 7.00 (1.972%)
Market Cap: £1.85b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

15 Nov 2018 07:00

RNS Number : 4064H
Caledonia Investments PLC
15 November 2018
 

 

 

 

APPOINTMENT OF CHIEF FINANCIAL OFFICER

 

The board of Caledonia Investments plc ("Caledonia" or the "Company") is pleased to announce that it has appointed Tim Livett as Caledonia's Chief Financial Officer with effect from 12 March 2019.

 

Tim will join Caledonia from the Wellcome Trust, where he has been Chief Financial Officer since 2014. Prior to this position, he worked for Virgin Atlantic for ten years, initially as Finance Director and latterly as Chief Financial Officer, having previously held senior financial positions at Hudson Global Resources and British Airways.

 

As previously announced, Stephen King, Caledonia's current Finance Director, will step down from the board and leave the Company on 30 November 2018, following the Company's half-year results. Caledonia's Finance team will report directly to the Chief Executive pending Tim Livett's arrival.

 

Commenting on the appointment, Will Wyatt, Caledonia's Chief Executive, said:

 

"We are delighted that Tim Livett will be joining our board. His knowledge and insight gained from his responsibilities at Wellcome, in particular from his risk and performance oversight of its asset management division, which manages the Trust's £23bn mixed asset portfolio, will be highly complementary to our management team."

 

"I would also like again to extend the board's thanks to Stephen King for his contribution to Caledonia over his past nine years as Finance Director and we wish him every success in the future."

 

Tim Livett said:

 

"I am thrilled to be joining Caledonia, a company with a unique approach and proven track record of identifying excellent investment opportunities to build long-term value. Caledonia has a long heritage and a bright future and I look forward to working with Will and the team."

 

15 November 2018

 

For further information please contact:

 

 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

 

 

 

 

 

Tulchan Communications

+44 20 7353 4200

Tom Murray

Lisa Jarrett-Kerr

 

 

 

 

 

Notes:

 

1. There are no disclosures to be made pursuant to LR 9.6.13 in relation to Mr Livett.

2. Mr Livett's remuneration package will be in accordance with Caledonia's approved remuneration policy and will include the following:

 

· A basic salary of £375,000;

· A bonus opportunity of up to 100% of basic salary, of which any bonus in excess of 50% of basic salary will be compulsorily deferred into Caledonia shares for three years under the Company's deferred bonus plan;

· An annual award of 150% of basic salary under the Company's performance share scheme, which will vest based on performance as to one-third over three years and two-thirds over five years;

· A pension entitlement (cash allowance or contribution) of 17.5% of basic salary;

· Other customary benefits, such as private medical cover and death-in-service insurance.

 

No special sign-on commitments or compensation payments for loss of benefits from his previous employer will be made in relation to Mr Livett's appointment.

 

3. Mr Livett and persons closely associated with him do not hold any shares in Caledonia.

 

4. Information required by section 430 (2B) of the Companies Act 2006 relating to Mr King's cessation as a director of the Company is available on Caledonia's website.

 

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of £2.0bn as at 31 October 2018. The Company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 51 years.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABZLLFVFFBFBL
Date   Source Headline
18th Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20267:00 amRNSCaledonia to invest in Blue Diamond Garden Centres
16th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20263:30 pmRNSAnnual report 2026 and notice of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20261:39 pmRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20269:00 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20265:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202611:02 amRNSCompletion of Stonehage Fleming sale
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20269:42 amRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:34 pmRNSDirector Declaration
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSBoard changes
19th May 20267:00 amRNSFinal Results
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSNotice of Results
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:32 pmRNSHolding(s) in Company
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 202611:00 amRNSNet Asset Value(s)
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20264:39 pmRNSDirector Declaration
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:47 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.